More on ELDN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/6/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Eledon Pharmaceuticals (NQ:ELDN)
Delayed: 2.98 --0 (-0%)
Prev. Close $2.98  
Open$2.98 
52 Wk High$ 
52 Wk Low$ 
Day High$2.98 
Day Low$2.98 
P/E N/A  
EPS$ 
Volume302 

Friends, Peers and Foes (?): NCEL NTRA (more...)

Aug 13, 2026 04:41 PM Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
Aug 13, 2026 04:32 PM Form 10-Q Eledon Pharmaceuticals, For: Jun 30
Aug 13, 2026 04:10 PM Form 8-K Eledon Pharmaceuticals, For: Aug 13
Aug 13, 2026 04:05 PM Eledon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Aug 4, 2026 05:23 PM Form 4 Eledon Pharmaceuticals, For: Jul 31 Filed by: Gros David-Alexandre C
Aug 4, 2026 05:22 PM Form 4 Eledon Pharmaceuticals, For: Jul 31 Filed by: Perrin Steven
Jul 31, 2026 10:17 AM Form SCHEDULE 13G Eledon Pharmaceuticals, Filed by: VANGUARD CAPITAL MANAGEMENT LLC
Jul 21, 2026 06:31 AM Rodman & Renshaw Starts Eledon Pharamceuticals (ELDN) at Buy
Jul 1, 2026 09:30 AM NewcelX gets FDA feedback supporting NCEL-101 diabetes trial path
Jul 1, 2026 09:30 AM NewcelX Announces Successful FDA Pre-IND Meeting with Clear Path Forward for NCEL-101 Toward Starting Clinical Trials for Type 1 Diabetes
View All Articles

Entities mentioned with ELDN

View All Entities